PRKAA1 and cancer: While cyclooxygenases (COX) and NFĸB are well-known targets of aspirin for its platelet-suppressive and cancer-preventive effects, aspirin also regulates the activity of AMP-activated protein kinase (AMPK) and PFKFB3 [7,9,12,13,14].